REYNOLDS MEDICAL LTD

Company Registration Number:
07736599 (England and Wales)

Unaudited micro entity accounts for the year ended 31 August 2023

Period of accounts

Start date: 01 September 2022

End date: 31 August 2023

REYNOLDS MEDICAL LTD

Contents of the Financial Statements

for the Period Ended 31 August 2023

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

REYNOLDS MEDICAL LTD

Company Information

for the Period Ended 31 August 2023




Registered office: 4-5
Bridge Street
Bath
Avon
BA2 4AP
Company Registration Number: 07736599 (England and Wales)

REYNOLDS MEDICAL LTD

Balance sheet

As at 31 August 2023


2023
£

2022
£
Fixed Assets: 5,459 10,857
Current assets: 168,194 175,047
Prepayments and accrued income: 500 1,000
Creditors: amounts falling due within one year: ( 54,042 ) ( 62,131 )
Net current assets (liabilities): 114,652 113,916
Total assets less current liabilities: 120,111 124,773
Total net assets (liabilities): 120,111 124,773
Capital and reserves: 120,111 124,773

REYNOLDS MEDICAL LTD

Balance sheet continued

For the year ending 31 August 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 21 December 2023
And Signed On Behalf Of The Board By:

Name: Nick Reynolds
Status: Director

The notes form part of these financial statements

REYNOLDS MEDICAL LTD

Footnotes to the Financial Statements

for the Period Ended 31 August 2023

  • 1. Employee Information

    Average number of employees: 2

REYNOLDS MEDICAL LTD

Footnotes to the Financial Statements

for the Period Ended 31 August 2023

  • 2. Off balance sheet disclosure

    No